Philadelphia Phillies v Atlanta Braves

Today’s decision punishes A-Rod, but it also gives Bud Selig new power

66 Comments

I think the most interesting thing about Alex Rodriguez’s suspension is that curious number of games: 162. It’s such a great number. It matches up so perfectly with a major league baseball season! I thought Ryan Braun’s suspension was interesting too: 65 games. When, as a matter of pure coincidence, I’m sure, the Milwaukee Brewers had 65 games left on their schedule. How neat that is!

It’s almost as if we now have a new matrix for drug suspensions:

  • First offense: 50 games
  • Second offense: 100 games
  • Third offense: lifetime ban
  • Offense by a guy who REALLY makes us look bad and we want to hammer: Until the end of the year, how ever many games that may be.

Which, however satisfying that may be — who doesn’t want A-Rod to just be gone for a season at this point? — is a departure from what Major League Baseball has done with suspensions in the past. Until Braun and now A-Rod, suspensions were for a set number of games, agreed-to beforehand in the Joint Drug Agreement. It was automatic, not a matter of personal judgment by Bud Selig or an arbitrator. We’re in new territory here.

The explanation I’ve seen from some on this — particularly Tom Verducci, but others have said it as well — is that the odd, convenient number of games is because the enforcement action was not based on testing, it was based on non-analytic information (Tony Bosch and the Biogenesis documents) and that when we’re in non-analytic land, the Commissioner has discretion.

Except that is not at all clear from either the terms of the CBA or the JDA. It’s apparently what Bud Selig asserted and, presumably, it’s a position the arbitrator validated in the A-Rod arbitration. But we don’t know, because his decision is sealed. I wonder if, given how much time A-Rod’s lawyers seemed to spend on claiming the existence of a vast conspiracy against their client, they bothered to spend much time arguing that point of the Commissioner’s authority. If they didn’t, that’s pretty awful lawyering.

In any event, that’s basically the effect of this ruling: a big grant of power to Bud Selig to exceed the penalties set forth in the JDA in cases that don’t involve a positive test. A power that, for whatever reason, he decided not to use for Nelson Cruz, Jhonny Peralta and all of the other Biogenesis players, but I suppose that’s convenient too. And, perversely, a power he would not have if the drug testing system he has put in place would have caught these players before we heard about it in the Miami New-Times. Indeed, the failure of the drug testing system worked to Selig’s benefit, which is kind of crazy itself if you think about.

But that’s neither here nor there. The real takeaway here is that Selig now has power in the drug enforcement world he didn’t have before and which he did not obtain via negotiation with the union. He obtained it by simply asserting it and seeing if he could make it stick.  He made it stick.

It’l be interesting to see if the union, under new leader Tony Clark, is going to make this an issue when the new CBA is negotiated or if they’re going to let Selig’s grab for power– his quite successful grab — stand.

Orioles are eying Welington Castillo as their primary catcher target

BALTIMORE, MD - SEPTEMBER 25: Welington Castillo #7 of the Arizona Diamondbacks warms up prior to taking an at bat against the Baltimore Orioles in the second inning at Oriole Park at Camden Yards on September 25, 2016 in Baltimore, Maryland. (Photo by Matt Hazlett/Getty Images)
Getty Images
Leave a comment

A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.

Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.

For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.

Report: Phillies agree to minor league deal with Daniel Nava

KANSAS CITY, MO - SEPTEMBER 12:  Daniel Nava #12 of the Kansas City Royals bats during the game against the Oakland Athletics at Kauffman Stadium on September 12, 2016 in Kansas City, Missouri.  (Photo by Jamie Squire/Getty Images)
Getty Images
2 Comments

The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.

Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.

Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.